Antibodies to Toxin B Are Protective AgainstClostridium difficileInfection Recurrence
Author(s) -
Swati B. Gupta,
Vinay Mehta,
Erik R. Dubberke,
Xuemei Zhao,
Marcus Dörr,
Dalya Güriş,
Deborah C. Molrine,
Mark D. Leney,
Mark A. Miller,
Marilyne Dupin,
T. Christopher Mast
Publication year - 2016
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciw364
Subject(s) - clostridium difficile , medicine , microbiology and biotechnology , antibody , toxin , clostridium difficile toxin a , clostridium difficile toxin b , immunology , virology , clostridium infections , antibiotics , biology
Although newer studies have evaluated risk factors for recurrent Clostridium difficile infection (CDI), the vast majority did not measure important biomarkers such as endogenous anti-toxin A and anti-toxin B antibody levels.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom